Skip to main content
Premium Trial:

Request an Annual Quote

Neil Day, Kate Johnson, Lawrence Bruder

Premium

Definiens has appointed Neil Day as its vice president of business development and marketing, the Munich, Germany-based image-analysis software firm said last week.

Dey joins Definiens from BioImagene, where he served as vice president of business development. Prior to that, he was head of business development at Impath. He has also held senior executive positions at Genmethrax, Thomas Jefferson Medical University, and Ciba-Geigy, Definiens said.


Kate Johnson has officially joined Cellumen as the company's vice president of discovery programs, the Pittsburgh-based company said last week. CBA News reported in June that Johnson would be joining Cellumen (see CBA News, 6/13/2005).

Johnson joins Cellumen from Eli Lilly, where she was the director of lead generation biology at Lilly's Center of Excellence in Research Triangle Park, NC, since 2001.


Lawrence Bruder has been promoted to president and COO of Guava Technologies, the company said last week (see related story, this issue).

Bruder joined Guava in 2004, and most recently held the title of vice president of corporate development and worldwide marketing. He has held vice-president-level positions at Applied Biosystems and Becton Dickinson, and has held various marketing, sales, and product management positions with Leica and Olympus. He holds a master of management degree from Kellogg Management School at Northwestern University, and a BS from Rochester Institute of Technology.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.